nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—Agranulocytosis—Azathioprine—Crohn's disease	0.00143	0.00149	CcSEcCtD
Citalopram—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00143	0.00149	CcSEcCtD
Citalopram—Decreased appetite—Mercaptopurine—Crohn's disease	0.00143	0.00149	CcSEcCtD
Citalopram—Weight increased—Mesalazine—Crohn's disease	0.00143	0.00149	CcSEcCtD
Citalopram—Weight decreased—Mesalazine—Crohn's disease	0.00142	0.00148	CcSEcCtD
Citalopram—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00142	0.00148	CcSEcCtD
Citalopram—Leukocytosis—Prednisone—Crohn's disease	0.00141	0.00147	CcSEcCtD
Citalopram—Pneumonia—Mesalazine—Crohn's disease	0.00141	0.00147	CcSEcCtD
Citalopram—Infestation NOS—Mesalazine—Crohn's disease	0.0014	0.00146	CcSEcCtD
Citalopram—Infestation—Mesalazine—Crohn's disease	0.0014	0.00146	CcSEcCtD
Citalopram—Hypercholesterolaemia—Prednisone—Crohn's disease	0.0014	0.00146	CcSEcCtD
Citalopram—Depression—Mesalazine—Crohn's disease	0.0014	0.00145	CcSEcCtD
Citalopram—Cataract—Prednisone—Crohn's disease	0.00139	0.00145	CcSEcCtD
Citalopram—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00139	0.00145	CcSEcCtD
Citalopram—Haemoglobin—Azathioprine—Crohn's disease	0.00139	0.00144	CcSEcCtD
Citalopram—Haemorrhage—Azathioprine—Crohn's disease	0.00138	0.00144	CcSEcCtD
Citalopram—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00137	0.00143	CcSEcCtD
Citalopram—Stomatitis—Mesalazine—Crohn's disease	0.00136	0.00142	CcSEcCtD
Citalopram—Jaundice—Mesalazine—Crohn's disease	0.00136	0.00142	CcSEcCtD
Citalopram—Conjunctivitis—Mesalazine—Crohn's disease	0.00136	0.00142	CcSEcCtD
Citalopram—Urinary tract infection—Mesalazine—Crohn's disease	0.00136	0.00142	CcSEcCtD
Citalopram—Sweating—Mesalazine—Crohn's disease	0.00134	0.0014	CcSEcCtD
Citalopram—Haematuria—Mesalazine—Crohn's disease	0.00133	0.00139	CcSEcCtD
Citalopram—Hiccups—Prednisone—Crohn's disease	0.00132	0.00138	CcSEcCtD
Citalopram—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00132	0.00138	CcSEcCtD
Citalopram—Epistaxis—Mesalazine—Crohn's disease	0.00132	0.00138	CcSEcCtD
Citalopram—Sinusitis—Mesalazine—Crohn's disease	0.00131	0.00137	CcSEcCtD
Citalopram—Agranulocytosis—Mesalazine—Crohn's disease	0.00131	0.00136	CcSEcCtD
Citalopram—Erythema multiforme—Azathioprine—Crohn's disease	0.0013	0.00136	CcSEcCtD
Citalopram—Body temperature increased—Mercaptopurine—Crohn's disease	0.0013	0.00135	CcSEcCtD
Citalopram—Haemoglobin—Mesalazine—Crohn's disease	0.00126	0.00132	CcSEcCtD
Citalopram—Rhinitis—Mesalazine—Crohn's disease	0.00126	0.00131	CcSEcCtD
Citalopram—Fluid retention—Prednisone—Crohn's disease	0.00126	0.00131	CcSEcCtD
Citalopram—Haemorrhage—Mesalazine—Crohn's disease	0.00126	0.00131	CcSEcCtD
Citalopram—Hepatitis—Mesalazine—Crohn's disease	0.00126	0.00131	CcSEcCtD
Citalopram—Pharyngitis—Mesalazine—Crohn's disease	0.00125	0.0013	CcSEcCtD
Citalopram—Immune system disorder—Azathioprine—Crohn's disease	0.00125	0.0013	CcSEcCtD
Citalopram—Mediastinal disorder—Azathioprine—Crohn's disease	0.00124	0.00129	CcSEcCtD
Citalopram—Neuropathy—Prednisone—Crohn's disease	0.00124	0.00129	CcSEcCtD
Citalopram—Urinary tract disorder—Mesalazine—Crohn's disease	0.00124	0.00129	CcSEcCtD
Citalopram—Oedema peripheral—Mesalazine—Crohn's disease	0.00124	0.00129	CcSEcCtD
Citalopram—Chills—Azathioprine—Crohn's disease	0.00124	0.00129	CcSEcCtD
Citalopram—Connective tissue disorder—Mesalazine—Crohn's disease	0.00123	0.00129	CcSEcCtD
Citalopram—Arrhythmia—Azathioprine—Crohn's disease	0.00123	0.00128	CcSEcCtD
Citalopram—Urethral disorder—Mesalazine—Crohn's disease	0.00123	0.00128	CcSEcCtD
Citalopram—Alopecia—Azathioprine—Crohn's disease	0.00122	0.00127	CcSEcCtD
Citalopram—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00121	0.00126	CcSEcCtD
Citalopram—Oesophagitis—Prednisone—Crohn's disease	0.00121	0.00126	CcSEcCtD
Citalopram—Ecchymosis—Prednisone—Crohn's disease	0.0012	0.00125	CcSEcCtD
Citalopram—Erythema multiforme—Mesalazine—Crohn's disease	0.00119	0.00124	CcSEcCtD
Citalopram—Eye disorder—Mesalazine—Crohn's disease	0.00117	0.00122	CcSEcCtD
Citalopram—Tinnitus—Mesalazine—Crohn's disease	0.00117	0.00122	CcSEcCtD
Citalopram—Cardiac disorder—Mesalazine—Crohn's disease	0.00117	0.00121	CcSEcCtD
Citalopram—Hyperkinesia—Prednisone—Crohn's disease	0.00115	0.0012	CcSEcCtD
Citalopram—Sepsis—Prednisone—Crohn's disease	0.00115	0.0012	CcSEcCtD
Citalopram—Angiopathy—Mesalazine—Crohn's disease	0.00114	0.00119	CcSEcCtD
Citalopram—Euphoric mood—Prednisone—Crohn's disease	0.00114	0.00118	CcSEcCtD
Citalopram—Immune system disorder—Mesalazine—Crohn's disease	0.00113	0.00118	CcSEcCtD
Citalopram—Mediastinal disorder—Mesalazine—Crohn's disease	0.00113	0.00118	CcSEcCtD
Citalopram—Chills—Mesalazine—Crohn's disease	0.00113	0.00117	CcSEcCtD
Citalopram—Diarrhoea—Mercaptopurine—Crohn's disease	0.00113	0.00117	CcSEcCtD
Citalopram—Ill-defined disorder—Azathioprine—Crohn's disease	0.00111	0.00116	CcSEcCtD
Citalopram—Alopecia—Mesalazine—Crohn's disease	0.00111	0.00116	CcSEcCtD
Citalopram—Anaemia—Azathioprine—Crohn's disease	0.00111	0.00116	CcSEcCtD
Citalopram—Diabetes mellitus—Prednisone—Crohn's disease	0.0011	0.00115	CcSEcCtD
Citalopram—Mental disorder—Mesalazine—Crohn's disease	0.0011	0.00115	CcSEcCtD
Citalopram—Erythema—Mesalazine—Crohn's disease	0.00109	0.00114	CcSEcCtD
Citalopram—Malaise—Azathioprine—Crohn's disease	0.00108	0.00113	CcSEcCtD
Citalopram—Flatulence—Mesalazine—Crohn's disease	0.00108	0.00112	CcSEcCtD
Citalopram—Leukopenia—Azathioprine—Crohn's disease	0.00107	0.00112	CcSEcCtD
Citalopram—Vascular purpura—Prednisone—Crohn's disease	0.00107	0.00112	CcSEcCtD
Citalopram—Tension—Mesalazine—Crohn's disease	0.00107	0.00112	CcSEcCtD
Citalopram—Dysgeusia—Mesalazine—Crohn's disease	0.00107	0.00112	CcSEcCtD
Citalopram—Nervousness—Mesalazine—Crohn's disease	0.00106	0.00111	CcSEcCtD
Citalopram—Back pain—Mesalazine—Crohn's disease	0.00106	0.0011	CcSEcCtD
Citalopram—Muscle spasms—Mesalazine—Crohn's disease	0.00105	0.0011	CcSEcCtD
Citalopram—Vomiting—Mercaptopurine—Crohn's disease	0.00105	0.00109	CcSEcCtD
Citalopram—Injury—Prednisone—Crohn's disease	0.00105	0.00109	CcSEcCtD
Citalopram—Rash—Mercaptopurine—Crohn's disease	0.00104	0.00108	CcSEcCtD
Citalopram—Dermatitis—Mercaptopurine—Crohn's disease	0.00104	0.00108	CcSEcCtD
Citalopram—Vision blurred—Mesalazine—Crohn's disease	0.00103	0.00107	CcSEcCtD
Citalopram—Tremor—Mesalazine—Crohn's disease	0.00102	0.00107	CcSEcCtD
Citalopram—Amnesia—Prednisone—Crohn's disease	0.00102	0.00107	CcSEcCtD
Citalopram—Increased appetite—Prednisone—Crohn's disease	0.00102	0.00107	CcSEcCtD
Citalopram—Arthralgia—Azathioprine—Crohn's disease	0.00102	0.00106	CcSEcCtD
Citalopram—Myalgia—Azathioprine—Crohn's disease	0.00102	0.00106	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00102	0.00106	CcSEcCtD
Citalopram—Ill-defined disorder—Mesalazine—Crohn's disease	0.00101	0.00106	CcSEcCtD
Citalopram—Anaemia—Mesalazine—Crohn's disease	0.00101	0.00105	CcSEcCtD
Citalopram—Discomfort—Azathioprine—Crohn's disease	0.00101	0.00105	CcSEcCtD
Citalopram—Angioedema—Mesalazine—Crohn's disease	0.000999	0.00104	CcSEcCtD
Citalopram—Purpura—Prednisone—Crohn's disease	0.000997	0.00104	CcSEcCtD
Citalopram—Malaise—Mesalazine—Crohn's disease	0.000986	0.00103	CcSEcCtD
Citalopram—Cardiac failure—Prednisone—Crohn's disease	0.000985	0.00103	CcSEcCtD
Citalopram—Vertigo—Mesalazine—Crohn's disease	0.000983	0.00102	CcSEcCtD
Citalopram—Syncope—Mesalazine—Crohn's disease	0.000981	0.00102	CcSEcCtD
Citalopram—Lethargy—Prednisone—Crohn's disease	0.000981	0.00102	CcSEcCtD
Citalopram—Leukopenia—Mesalazine—Crohn's disease	0.000979	0.00102	CcSEcCtD
Citalopram—Nausea—Mercaptopurine—Crohn's disease	0.000977	0.00102	CcSEcCtD
Citalopram—Infection—Azathioprine—Crohn's disease	0.000974	0.00101	CcSEcCtD
Citalopram—Palpitations—Mesalazine—Crohn's disease	0.000967	0.00101	CcSEcCtD
Citalopram—Loss of consciousness—Mesalazine—Crohn's disease	0.000961	0.001	CcSEcCtD
Citalopram—Osteoarthritis—Prednisone—Crohn's disease	0.000961	0.001	CcSEcCtD
Citalopram—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000961	0.001	CcSEcCtD
Citalopram—Thrombocytopenia—Azathioprine—Crohn's disease	0.000959	0.000999	CcSEcCtD
Citalopram—Cough—Mesalazine—Crohn's disease	0.000954	0.000994	CcSEcCtD
Citalopram—Skin disorder—Azathioprine—Crohn's disease	0.000952	0.000992	CcSEcCtD
Citalopram—Affect lability—Prednisone—Crohn's disease	0.000946	0.000985	CcSEcCtD
Citalopram—Hypertension—Mesalazine—Crohn's disease	0.000944	0.000984	CcSEcCtD
Citalopram—Psychotic disorder—Prednisone—Crohn's disease	0.000938	0.000978	CcSEcCtD
Citalopram—Chest pain—Mesalazine—Crohn's disease	0.000931	0.00097	CcSEcCtD
Citalopram—Myalgia—Mesalazine—Crohn's disease	0.000931	0.00097	CcSEcCtD
Citalopram—Arthralgia—Mesalazine—Crohn's disease	0.000931	0.00097	CcSEcCtD
Citalopram—Anxiety—Mesalazine—Crohn's disease	0.000928	0.000967	CcSEcCtD
Citalopram—Face oedema—Prednisone—Crohn's disease	0.000928	0.000966	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000925	0.000963	CcSEcCtD
Citalopram—Discomfort—Mesalazine—Crohn's disease	0.00092	0.000958	CcSEcCtD
Citalopram—Irritability—Prednisone—Crohn's disease	0.000917	0.000955	CcSEcCtD
Citalopram—Hypotension—Azathioprine—Crohn's disease	0.000916	0.000954	CcSEcCtD
Citalopram—Cardiac arrest—Prednisone—Crohn's disease	0.000914	0.000952	CcSEcCtD
Citalopram—Dry mouth—Mesalazine—Crohn's disease	0.000911	0.000949	CcSEcCtD
Citalopram—Mood swings—Prednisone—Crohn's disease	0.00091	0.000948	CcSEcCtD
Citalopram—Confusional state—Mesalazine—Crohn's disease	0.0009	0.000938	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000893	0.00093	CcSEcCtD
Citalopram—Anaphylactic shock—Mesalazine—Crohn's disease	0.000893	0.00093	CcSEcCtD
Citalopram—Oedema—Mesalazine—Crohn's disease	0.000893	0.00093	CcSEcCtD
Citalopram—Infection—Mesalazine—Crohn's disease	0.000887	0.000924	CcSEcCtD
Citalopram—Dry skin—Prednisone—Crohn's disease	0.000881	0.000917	CcSEcCtD
Citalopram—Shock—Mesalazine—Crohn's disease	0.000878	0.000915	CcSEcCtD
Citalopram—Nervous system disorder—Mesalazine—Crohn's disease	0.000875	0.000912	CcSEcCtD
Citalopram—Hypokalaemia—Prednisone—Crohn's disease	0.000874	0.000911	CcSEcCtD
Citalopram—Thrombocytopenia—Mesalazine—Crohn's disease	0.000874	0.00091	CcSEcCtD
Citalopram—Tachycardia—Mesalazine—Crohn's disease	0.000871	0.000907	CcSEcCtD
Citalopram—Skin disorder—Mesalazine—Crohn's disease	0.000867	0.000903	CcSEcCtD
Citalopram—Hyperhidrosis—Mesalazine—Crohn's disease	0.000863	0.000899	CcSEcCtD
Citalopram—Anorexia—Mesalazine—Crohn's disease	0.000851	0.000886	CcSEcCtD
Citalopram—Muscular weakness—Prednisone—Crohn's disease	0.000847	0.000883	CcSEcCtD
Citalopram—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000847	0.000883	CcSEcCtD
Citalopram—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000846	0.000881	CcSEcCtD
Citalopram—Abdominal distension—Prednisone—Crohn's disease	0.000836	0.000871	CcSEcCtD
Citalopram—Hypotension—Mesalazine—Crohn's disease	0.000834	0.000869	CcSEcCtD
Citalopram—Pancreatitis—Prednisone—Crohn's disease	0.000814	0.000848	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000813	0.000847	CcSEcCtD
Citalopram—Sweating increased—Prednisone—Crohn's disease	0.000809	0.000843	CcSEcCtD
Citalopram—Feeling abnormal—Azathioprine—Crohn's disease	0.000808	0.000841	CcSEcCtD
Citalopram—Insomnia—Mesalazine—Crohn's disease	0.000807	0.000841	CcSEcCtD
Citalopram—Paraesthesia—Mesalazine—Crohn's disease	0.000802	0.000835	CcSEcCtD
Citalopram—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000801	0.000835	CcSEcCtD
Citalopram—Dyspnoea—Mesalazine—Crohn's disease	0.000796	0.000829	CcSEcCtD
Citalopram—Somnolence—Mesalazine—Crohn's disease	0.000794	0.000827	CcSEcCtD
Citalopram—Dyspepsia—Mesalazine—Crohn's disease	0.000786	0.000818	CcSEcCtD
Citalopram—Decreased appetite—Mesalazine—Crohn's disease	0.000776	0.000808	CcSEcCtD
Citalopram—Abdominal pain—Azathioprine—Crohn's disease	0.000775	0.000807	CcSEcCtD
Citalopram—Body temperature increased—Azathioprine—Crohn's disease	0.000775	0.000807	CcSEcCtD
Citalopram—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000771	0.000803	CcSEcCtD
Citalopram—Fatigue—Mesalazine—Crohn's disease	0.00077	0.000802	CcSEcCtD
Citalopram—Erectile dysfunction—Prednisone—Crohn's disease	0.000765	0.000797	CcSEcCtD
Citalopram—Pain—Mesalazine—Crohn's disease	0.000763	0.000795	CcSEcCtD
Citalopram—Constipation—Mesalazine—Crohn's disease	0.000763	0.000795	CcSEcCtD
Citalopram—Weight increased—Prednisone—Crohn's disease	0.000756	0.000787	CcSEcCtD
Citalopram—Weight decreased—Prednisone—Crohn's disease	0.000751	0.000783	CcSEcCtD
Citalopram—Hyperglycaemia—Prednisone—Crohn's disease	0.000749	0.00078	CcSEcCtD
Citalopram—Depression—Prednisone—Crohn's disease	0.000738	0.000769	CcSEcCtD
Citalopram—Feeling abnormal—Mesalazine—Crohn's disease	0.000736	0.000766	CcSEcCtD
Citalopram—Acute coronary syndrome—Prednisone—Crohn's disease	0.00073	0.00076	CcSEcCtD
Citalopram—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00073	0.00076	CcSEcCtD
Citalopram—Myocardial infarction—Prednisone—Crohn's disease	0.000726	0.000756	CcSEcCtD
Citalopram—Neuropathy peripheral—Prednisone—Crohn's disease	0.000726	0.000756	CcSEcCtD
Citalopram—Hypersensitivity—Azathioprine—Crohn's disease	0.000722	0.000752	CcSEcCtD
Citalopram—Urticaria—Mesalazine—Crohn's disease	0.000709	0.000739	CcSEcCtD
Citalopram—Abdominal pain—Mesalazine—Crohn's disease	0.000706	0.000735	CcSEcCtD
Citalopram—Body temperature increased—Mesalazine—Crohn's disease	0.000706	0.000735	CcSEcCtD
Citalopram—Bradycardia—Prednisone—Crohn's disease	0.000677	0.000705	CcSEcCtD
Citalopram—Diarrhoea—Azathioprine—Crohn's disease	0.00067	0.000698	CcSEcCtD
Citalopram—Haemoglobin—Prednisone—Crohn's disease	0.000668	0.000696	CcSEcCtD
Citalopram—Haemorrhage—Prednisone—Crohn's disease	0.000665	0.000692	CcSEcCtD
Citalopram—Hallucination—Prednisone—Crohn's disease	0.000661	0.000689	CcSEcCtD
Citalopram—Hypersensitivity—Mesalazine—Crohn's disease	0.000658	0.000685	CcSEcCtD
Citalopram—Connective tissue disorder—Prednisone—Crohn's disease	0.000653	0.00068	CcSEcCtD
Citalopram—Dizziness—Azathioprine—Crohn's disease	0.000648	0.000675	CcSEcCtD
Citalopram—Asthenia—Mesalazine—Crohn's disease	0.00064	0.000667	CcSEcCtD
Citalopram—Pruritus—Mesalazine—Crohn's disease	0.000632	0.000658	CcSEcCtD
Citalopram—Vomiting—Azathioprine—Crohn's disease	0.000623	0.000649	CcSEcCtD
Citalopram—Eye disorder—Prednisone—Crohn's disease	0.000621	0.000647	CcSEcCtD
Citalopram—Rash—Azathioprine—Crohn's disease	0.000618	0.000644	CcSEcCtD
Citalopram—Dermatitis—Azathioprine—Crohn's disease	0.000617	0.000643	CcSEcCtD
Citalopram—Flushing—Prednisone—Crohn's disease	0.000617	0.000643	CcSEcCtD
Citalopram—Headache—Azathioprine—Crohn's disease	0.000614	0.000639	CcSEcCtD
Citalopram—Diarrhoea—Mesalazine—Crohn's disease	0.000611	0.000636	CcSEcCtD
Citalopram—Angiopathy—Prednisone—Crohn's disease	0.000603	0.000628	CcSEcCtD
Citalopram—Immune system disorder—Prednisone—Crohn's disease	0.0006	0.000625	CcSEcCtD
Citalopram—Arrhythmia—Prednisone—Crohn's disease	0.000594	0.000619	CcSEcCtD
Citalopram—Dizziness—Mesalazine—Crohn's disease	0.00059	0.000615	CcSEcCtD
Citalopram—Alopecia—Prednisone—Crohn's disease	0.000587	0.000612	CcSEcCtD
Citalopram—Mental disorder—Prednisone—Crohn's disease	0.000582	0.000607	CcSEcCtD
Citalopram—Nausea—Azathioprine—Crohn's disease	0.000582	0.000606	CcSEcCtD
Citalopram—Malnutrition—Prednisone—Crohn's disease	0.000579	0.000603	CcSEcCtD
Citalopram—Erythema—Prednisone—Crohn's disease	0.000579	0.000603	CcSEcCtD
Citalopram—Vomiting—Mesalazine—Crohn's disease	0.000568	0.000591	CcSEcCtD
Citalopram—Rash—Mesalazine—Crohn's disease	0.000563	0.000586	CcSEcCtD
Citalopram—Dermatitis—Mesalazine—Crohn's disease	0.000562	0.000586	CcSEcCtD
Citalopram—Headache—Mesalazine—Crohn's disease	0.000559	0.000583	CcSEcCtD
Citalopram—Vision blurred—Prednisone—Crohn's disease	0.000545	0.000568	CcSEcCtD
Citalopram—Ill-defined disorder—Prednisone—Crohn's disease	0.000537	0.000559	CcSEcCtD
Citalopram—Anaemia—Prednisone—Crohn's disease	0.000535	0.000557	CcSEcCtD
Citalopram—Agitation—Prednisone—Crohn's disease	0.000532	0.000554	CcSEcCtD
Citalopram—Nausea—Mesalazine—Crohn's disease	0.00053	0.000552	CcSEcCtD
Citalopram—Angioedema—Prednisone—Crohn's disease	0.000529	0.000551	CcSEcCtD
Citalopram—Malaise—Prednisone—Crohn's disease	0.000522	0.000544	CcSEcCtD
Citalopram—Vertigo—Prednisone—Crohn's disease	0.00052	0.000542	CcSEcCtD
Citalopram—Syncope—Prednisone—Crohn's disease	0.000519	0.000541	CcSEcCtD
Citalopram—Loss of consciousness—Prednisone—Crohn's disease	0.000509	0.00053	CcSEcCtD
Citalopram—Convulsion—Prednisone—Crohn's disease	0.000501	0.000522	CcSEcCtD
Citalopram—Hypertension—Prednisone—Crohn's disease	0.0005	0.00052	CcSEcCtD
Citalopram—Myalgia—Prednisone—Crohn's disease	0.000493	0.000513	CcSEcCtD
Citalopram—Arthralgia—Prednisone—Crohn's disease	0.000493	0.000513	CcSEcCtD
Citalopram—Anxiety—Prednisone—Crohn's disease	0.000491	0.000511	CcSEcCtD
Citalopram—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000489	0.00051	CcSEcCtD
Citalopram—Discomfort—Prednisone—Crohn's disease	0.000487	0.000507	CcSEcCtD
Citalopram—Oedema—Prednisone—Crohn's disease	0.000472	0.000492	CcSEcCtD
Citalopram—Anaphylactic shock—Prednisone—Crohn's disease	0.000472	0.000492	CcSEcCtD
Citalopram—Infection—Prednisone—Crohn's disease	0.000469	0.000489	CcSEcCtD
Citalopram—Shock—Prednisone—Crohn's disease	0.000465	0.000484	CcSEcCtD
Citalopram—Nervous system disorder—Prednisone—Crohn's disease	0.000463	0.000482	CcSEcCtD
Citalopram—Tachycardia—Prednisone—Crohn's disease	0.000461	0.00048	CcSEcCtD
Citalopram—Skin disorder—Prednisone—Crohn's disease	0.000459	0.000478	CcSEcCtD
Citalopram—Hyperhidrosis—Prednisone—Crohn's disease	0.000457	0.000476	CcSEcCtD
Citalopram—Anorexia—Prednisone—Crohn's disease	0.00045	0.000469	CcSEcCtD
Citalopram—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00043	0.000448	CcSEcCtD
Citalopram—Insomnia—Prednisone—Crohn's disease	0.000427	0.000445	CcSEcCtD
Citalopram—Paraesthesia—Prednisone—Crohn's disease	0.000424	0.000442	CcSEcCtD
Citalopram—Dyspepsia—Prednisone—Crohn's disease	0.000416	0.000433	CcSEcCtD
Citalopram—Decreased appetite—Prednisone—Crohn's disease	0.000411	0.000428	CcSEcCtD
Citalopram—Fatigue—Prednisone—Crohn's disease	0.000407	0.000424	CcSEcCtD
Citalopram—Constipation—Prednisone—Crohn's disease	0.000404	0.000421	CcSEcCtD
Citalopram—Feeling abnormal—Prednisone—Crohn's disease	0.000389	0.000405	CcSEcCtD
Citalopram—Gastrointestinal pain—Prednisone—Crohn's disease	0.000386	0.000402	CcSEcCtD
Citalopram—Urticaria—Prednisone—Crohn's disease	0.000375	0.000391	CcSEcCtD
Citalopram—Abdominal pain—Prednisone—Crohn's disease	0.000373	0.000389	CcSEcCtD
Citalopram—Body temperature increased—Prednisone—Crohn's disease	0.000373	0.000389	CcSEcCtD
Citalopram—Hypersensitivity—Prednisone—Crohn's disease	0.000348	0.000362	CcSEcCtD
Citalopram—Asthenia—Prednisone—Crohn's disease	0.000339	0.000353	CcSEcCtD
Citalopram—Pruritus—Prednisone—Crohn's disease	0.000334	0.000348	CcSEcCtD
Citalopram—Diarrhoea—Prednisone—Crohn's disease	0.000323	0.000337	CcSEcCtD
Citalopram—Dizziness—Prednisone—Crohn's disease	0.000312	0.000325	CcSEcCtD
Citalopram—Vomiting—Prednisone—Crohn's disease	0.0003	0.000313	CcSEcCtD
Citalopram—Rash—Prednisone—Crohn's disease	0.000298	0.00031	CcSEcCtD
Citalopram—Dermatitis—Prednisone—Crohn's disease	0.000297	0.00031	CcSEcCtD
Citalopram—Headache—Prednisone—Crohn's disease	0.000296	0.000308	CcSEcCtD
Citalopram—Nausea—Prednisone—Crohn's disease	0.000281	0.000292	CcSEcCtD
Citalopram—HRH1—Signaling by GPCR—CCR9—Crohn's disease	5.71e-05	0.00143	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CCR9—Crohn's disease	5.69e-05	0.00142	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—IL1B—Crohn's disease	5.67e-05	0.00142	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MLN—Crohn's disease	5.62e-05	0.0014	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CCR9—Crohn's disease	5.6e-05	0.0014	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	5.58e-05	0.00139	CbGpPWpGaD
Citalopram—SLC6A3—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.41e-05	0.00135	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	5.33e-05	0.00133	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—GPR65—Crohn's disease	5.31e-05	0.00133	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—GPR65—Crohn's disease	5.29e-05	0.00132	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—GPR65—Crohn's disease	5.21e-05	0.0013	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TAGAP—Crohn's disease	5.14e-05	0.00128	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ACKR2—Crohn's disease	5.13e-05	0.00128	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ACKR2—Crohn's disease	5.12e-05	0.00128	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.11e-05	0.00128	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.11e-05	0.00128	CbGpPWpGaD
Citalopram—SLC6A4—SIDS Susceptibility Pathways—IL6—Crohn's disease	5.09e-05	0.00127	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	5.07e-05	0.00127	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	5.07e-05	0.00127	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ACKR2—Crohn's disease	5.04e-05	0.00126	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MLN—Crohn's disease	4.87e-05	0.00122	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MLN—Crohn's disease	4.85e-05	0.00121	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	4.84e-05	0.00121	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	4.82e-05	0.0012	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CCR6—Crohn's disease	4.81e-05	0.0012	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.79e-05	0.0012	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MLN—Crohn's disease	4.77e-05	0.00119	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	4.75e-05	0.00119	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	4.61e-05	0.00115	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	4.6e-05	0.00115	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	4.55e-05	0.00114	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	4.53e-05	0.00113	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—RSPO3—Crohn's disease	4.49e-05	0.00112	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	4.46e-05	0.00111	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TAGAP—Crohn's disease	4.45e-05	0.00111	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TAGAP—Crohn's disease	4.44e-05	0.00111	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TAGAP—Crohn's disease	4.37e-05	0.00109	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CCR6—Crohn's disease	4.36e-05	0.00109	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.29e-05	0.00107	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SEL1L—Crohn's disease	4.26e-05	0.00106	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—PTGER4—Crohn's disease	4.23e-05	0.00106	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CCR6—Crohn's disease	4.16e-05	0.00104	CbGpPWpGaD
Citalopram—SLC6A4—Circadian rythm related genes—IL6—Crohn's disease	4.16e-05	0.00104	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CCR6—Crohn's disease	4.15e-05	0.00104	CbGpPWpGaD
Citalopram—ABCB1—Allograft Rejection—TNF—Crohn's disease	4.12e-05	0.00103	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CCR6—Crohn's disease	4.09e-05	0.00102	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.98e-05	0.000995	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCR9—Crohn's disease	3.89e-05	0.000972	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RSPO3—Crohn's disease	3.89e-05	0.000972	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RSPO3—Crohn's disease	3.88e-05	0.000968	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—MTMR3—Crohn's disease	3.87e-05	0.000966	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—PTGER4—Crohn's disease	3.84e-05	0.00096	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RSPO3—Crohn's disease	3.82e-05	0.000953	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.79e-05	0.000948	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—MTMR3—Crohn's disease	3.79e-05	0.000946	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CCR6—Crohn's disease	3.78e-05	0.000945	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	3.77e-05	0.000942	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.73e-05	0.000932	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CCR6—Crohn's disease	3.71e-05	0.000927	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SEL1L—Crohn's disease	3.69e-05	0.000921	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	3.68e-05	0.000918	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—PTGER4—Crohn's disease	3.67e-05	0.000916	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	3.65e-05	0.000913	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—GPR65—Crohn's disease	3.62e-05	0.000904	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SEL1L—Crohn's disease	3.62e-05	0.000904	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—IL3—Crohn's disease	3.6e-05	0.0009	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.6e-05	0.000899	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—PTGER4—Crohn's disease	3.6e-05	0.000899	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—RASGRP1—Crohn's disease	3.49e-05	0.000871	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	3.44e-05	0.000859	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCR9—Crohn's disease	3.37e-05	0.000842	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCR9—Crohn's disease	3.36e-05	0.00084	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PLA2G4F—Crohn's disease	3.36e-05	0.000838	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—PTGER4—Crohn's disease	3.33e-05	0.000832	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	3.32e-05	0.000829	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCR9—Crohn's disease	3.31e-05	0.000827	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL3—Crohn's disease	3.27e-05	0.000817	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—PTGER4—Crohn's disease	3.27e-05	0.000816	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—RASGRP1—Crohn's disease	3.17e-05	0.000791	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	3.16e-05	0.00079	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—GPR65—Crohn's disease	3.14e-05	0.000783	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—GPR65—Crohn's disease	3.13e-05	0.000781	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—IL3—Crohn's disease	3.12e-05	0.00078	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.12e-05	0.000779	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	3.11e-05	0.000778	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.11e-05	0.000776	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—ALB—Crohn's disease	3.1e-05	0.000775	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GPR65—Crohn's disease	3.08e-05	0.000768	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—IL3—Crohn's disease	3.06e-05	0.000765	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.06e-05	0.000764	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—RASGRP1—Crohn's disease	3.02e-05	0.000754	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—FADS1—Crohn's disease	3.01e-05	0.000753	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	3.01e-05	0.000752	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	3.01e-05	0.000752	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—RASGRP1—Crohn's disease	2.96e-05	0.00074	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—FADS1—Crohn's disease	2.95e-05	0.000737	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—MTMR3—Crohn's disease	2.92e-05	0.00073	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—MTMR3—Crohn's disease	2.85e-05	0.000713	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL3—Crohn's disease	2.84e-05	0.000708	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL3—Crohn's disease	2.83e-05	0.000706	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GPX4—Crohn's disease	2.82e-05	0.000705	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL3—Crohn's disease	2.78e-05	0.000695	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GPX4—Crohn's disease	2.76e-05	0.00069	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—ALB—Crohn's disease	2.75e-05	0.000686	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—RASGRP1—Crohn's disease	2.74e-05	0.000685	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—CXCL8—Crohn's disease	2.74e-05	0.000685	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	2.73e-05	0.000683	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.73e-05	0.000682	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GCKR—Crohn's disease	2.73e-05	0.000681	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	2.69e-05	0.000672	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MTMR3—Crohn's disease	2.69e-05	0.000672	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	2.68e-05	0.000669	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GCKR—Crohn's disease	2.67e-05	0.000667	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CCR6—Crohn's disease	2.58e-05	0.000644	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—IL2RA—Crohn's disease	2.52e-05	0.000631	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	2.49e-05	0.000622	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—CXCL8—Crohn's disease	2.37e-05	0.000593	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	2.37e-05	0.000591	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.37e-05	0.000591	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.36e-05	0.000589	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—RBX1—Crohn's disease	2.33e-05	0.000582	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	2.33e-05	0.000582	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	2.32e-05	0.00058	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL2RA—Crohn's disease	2.29e-05	0.000573	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MTMR3—Crohn's disease	2.28e-05	0.000569	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—FADS1—Crohn's disease	2.28e-05	0.000569	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PTGER4—Crohn's disease	2.27e-05	0.000567	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CCR6—Crohn's disease	2.23e-05	0.000558	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CCR6—Crohn's disease	2.23e-05	0.000556	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—FADS1—Crohn's disease	2.22e-05	0.000555	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	2.19e-05	0.000548	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—IL2RA—Crohn's disease	2.19e-05	0.000546	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	2.18e-05	0.000545	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	2.15e-05	0.000536	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GPX4—Crohn's disease	2.13e-05	0.000533	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—FADS1—Crohn's disease	2.09e-05	0.000523	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GPX4—Crohn's disease	2.08e-05	0.00052	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.07e-05	0.000516	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GCKR—Crohn's disease	2.06e-05	0.000514	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—UBE2D1—Crohn's disease	2.04e-05	0.000511	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.03e-05	0.000507	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RBX1—Crohn's disease	2.02e-05	0.000505	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RBX1—Crohn's disease	2.01e-05	0.000503	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GCKR—Crohn's disease	2.01e-05	0.000502	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	1.99e-05	0.000496	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	1.98e-05	0.000495	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	1.98e-05	0.000495	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	1.98e-05	0.000495	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PTGER4—Crohn's disease	1.97e-05	0.000491	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GPX4—Crohn's disease	1.96e-05	0.00049	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	1.96e-05	0.00049	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	1.95e-05	0.000487	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL3—Crohn's disease	1.93e-05	0.000483	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	1.93e-05	0.000482	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GCKR—Crohn's disease	1.89e-05	0.000473	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	1.87e-05	0.000467	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—FADS1—Crohn's disease	1.77e-05	0.000443	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	1.77e-05	0.000443	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	1.77e-05	0.000441	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.76e-05	0.000439	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	1.74e-05	0.000434	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RIPK2—Crohn's disease	1.72e-05	0.000429	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	1.71e-05	0.000428	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	1.7e-05	0.000424	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	1.69e-05	0.000423	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	1.69e-05	0.000421	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL3—Crohn's disease	1.68e-05	0.000418	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL3—Crohn's disease	1.67e-05	0.000417	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GPX4—Crohn's disease	1.66e-05	0.000415	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL3—Crohn's disease	1.64e-05	0.000411	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	1.62e-05	0.000405	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	1.62e-05	0.000403	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	1.62e-05	0.000403	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GCKR—Crohn's disease	1.6e-05	0.000401	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	1.59e-05	0.000397	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	1.55e-05	0.000387	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	1.54e-05	0.000385	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.47e-05	0.000368	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	1.47e-05	0.000367	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SOCS1—Crohn's disease	1.47e-05	0.000367	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	1.47e-05	0.000366	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	1.46e-05	0.000365	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	1.46e-05	0.000365	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	1.44e-05	0.00036	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	1.44e-05	0.00036	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	1.41e-05	0.000351	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—TYK2—Crohn's disease	1.4e-05	0.00035	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	1.4e-05	0.000348	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	1.37e-05	0.000343	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—FADS1—Crohn's disease	1.37e-05	0.000342	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.37e-05	0.000341	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	1.35e-05	0.000338	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	1.34e-05	0.000335	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	1.34e-05	0.000334	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—JAK2—Crohn's disease	1.34e-05	0.000334	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	1.33e-05	0.000332	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	1.32e-05	0.000329	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	1.31e-05	0.000327	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.29e-05	0.000322	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GPX4—Crohn's disease	1.28e-05	0.00032	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SMAD3—Crohn's disease	1.27e-05	0.000317	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	1.26e-05	0.000316	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	1.24e-05	0.000311	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GCKR—Crohn's disease	1.24e-05	0.000309	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	1.22e-05	0.000304	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	1.21e-05	0.000303	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	1.2e-05	0.000299	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL2RA—Crohn's disease	1.17e-05	0.000293	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	1.17e-05	0.000292	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	1.15e-05	0.000288	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.15e-05	0.000286	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1e-05	0.000251	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TYK2—Crohn's disease	9.54e-06	0.000238	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—JAK2—Crohn's disease	9.1e-06	0.000227	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ALB—Crohn's disease	8.67e-06	0.000217	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ALB—Crohn's disease	8.5e-06	0.000212	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	8.31e-06	0.000208	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TYK2—Crohn's disease	8.27e-06	0.000207	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TYK2—Crohn's disease	8.24e-06	0.000206	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	8.11e-06	0.000203	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—IL6—Crohn's disease	7.9e-06	0.000197	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—JAK2—Crohn's disease	7.89e-06	0.000197	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—JAK2—Crohn's disease	7.86e-06	0.000196	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	7.74e-06	0.000193	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTGS2—Crohn's disease	7.59e-06	0.00019	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTGS2—Crohn's disease	7.43e-06	0.000186	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CXCL8—Crohn's disease	7.2e-06	0.00018	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	7.18e-06	0.000179	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	7.06e-06	0.000176	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—IL6—Crohn's disease	6.85e-06	0.000171	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—IL6—Crohn's disease	6.82e-06	0.00017	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	6.72e-06	0.000168	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—STAT3—Crohn's disease	6.68e-06	0.000167	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ALB—Crohn's disease	6.55e-06	0.000164	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—ALB—Crohn's disease	6.4e-06	0.00016	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ALB—Crohn's disease	6.03e-06	0.000151	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—STAT3—Crohn's disease	5.79e-06	0.000145	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—STAT3—Crohn's disease	5.77e-06	0.000144	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTGS2—Crohn's disease	5.73e-06	0.000143	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	5.68e-06	0.000142	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTGS2—Crohn's disease	5.6e-06	0.00014	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTGS2—Crohn's disease	5.27e-06	0.000132	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ALB—Crohn's disease	5.11e-06	0.000128	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IL6—Crohn's disease	4.67e-06	0.000117	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTGS2—Crohn's disease	4.47e-06	0.000112	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IL6—Crohn's disease	4.04e-06	0.000101	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IL6—Crohn's disease	4.03e-06	0.000101	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IL6—Crohn's disease	3.97e-06	9.91e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ALB—Crohn's disease	3.94e-06	9.84e-05	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.45e-06	8.61e-05	CbGpPWpGaD
